Literature DB >> 24658375

All-trans retinoic acid-induced inflammatory myositis in a patient with acute promyelocytic leukemia.

Lydia H Pecker, Jason Tsai, Anne Angiolillo.   

Abstract

All-trans retinoic acid (ATRA), a component of standard therapy for acute promyelocytic leukemia (APL), is associated with potentially serious but treatable adverse effects involving numerous organ systems, including rare skeletal muscle involvement. Only a handful of cases of ATRA-induced myositis in children have been reported, and none in the radiology literature. We present such a case in a 15-year-old boy with APL, where recognition of imaging findings played a crucial role in making the diagnosis and facilitated prompt, effective treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24658375     DOI: 10.1007/s00247-014-2951-y

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  7 in total

1.  All-trans-retinoic acid-induced myositis: a description of two patients.

Authors:  H J van Der Vliet; A E Roberson; M C Hogan; C E Morales; S C Crader; L Letendre; R K Pruthi
Journal:  Am J Hematol       Date:  2000-02       Impact factor: 10.047

2.  A case of all-trans retinoic acid-induced myositis in the treatment of acute promyelocytic leukaemia.

Authors:  K H Chan; S L S Yuen; D Joshua
Journal:  Clin Lab Haematol       Date:  2005-12

3.  All-trans-retinoic acid-induced myositis in a child with acute promyelocytic leukemia.

Authors:  Funda Erkasar Citak; Ustun Ezer; Emel Akkaya; Nilgun Ozbulbul; Muhterem Bahce; Ahmet Emin Kurekci
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

4.  All Trans Retinoic Acid (ATRA) induced myositis.

Authors:  M V Manglani; P Balamurugan
Journal:  Indian Pediatr       Date:  2009-10       Impact factor: 1.411

5.  Induction mortality, ATRA administration, and resource utilization in a nationally representative cohort of children with acute promyelocytic leukemia in the United States from 1999 to 2009.

Authors:  Brian T Fisher; Sonia Singh; Yuan-Shung Huang; Yimei Li; John Gregory; Dana Walker; Alix E Seif; Marko Kavcic; Richard Aplenc
Journal:  Pediatr Blood Cancer       Date:  2013-07-18       Impact factor: 3.167

6.  Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.

Authors:  Pau Montesinos; Juan M Bergua; Edo Vellenga; Chelo Rayón; Ricardo Parody; Javier de la Serna; Angel León; Jordi Esteve; Gustavo Milone; Guillermo Debén; Concha Rivas; Marcos González; Mar Tormo; Joaquín Díaz-Mediavilla; Jose D González; Silvia Negri; Elena Amutio; Salut Brunet; Bob Lowenberg; Miguel A Sanz
Journal:  Blood       Date:  2008-10-22       Impact factor: 22.113

7.  A Sweet-like syndrome manifesting as gingival hyperplasia and myositis without cutaneous involvement.

Authors:  S R Melinkeri; R K Gupta; S Dabadghao
Journal:  Ann Hematol       Date:  2002-06-13       Impact factor: 3.673

  7 in total
  1 in total

1.  Myositis Induced by Isotretinoin: A Case Report and Literature Review.

Authors:  Julián Alejandro Rivillas; Víctor Alfonso Santos Andrade; Andrés Alberto Hormaza-Jaramillo
Journal:  Am J Case Rep       Date:  2020-01-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.